Physician profile
Robert Crew Edens
NPI 1205225893
$4,045.67
in general payments reported to CMS, 2019-2025
15 companies · $752 in 2025
The $752 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $892 · 2022: $573 · 2023: $940 · 2024: $888 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,578 · Education: $2.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,578.07 |
| Education | $2.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,488.15 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Gilead Sciences, INC. | $1,041.52 | 2021-2025 | Descovy |
| Lilly USA, LLC | $681.98 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $258.96 | 2021-2025 | Shingrix, Arexvy |
| Viiv Healthcare Company | $217.10 | 2022-2024 | Apretude |
| Exact Sciences Corporation | $106.01 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $42.02 | 2021-2022 | |
| Boston Scientific Corporation | $39.28 | 2023 | |
| Merck Sharp & Dohme LLC | $32.67 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Amarin Pharma, INC. | $28.18 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.97 | 2021 | |
| Amgen INC. | $25.82 | 2021-2022 | |
| Abbott Laboratories | $23.98 | 2022 | |
| Abbvie INC. | $19.68 | 2021 | |
| Dynavax Technologies Corporation | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Edens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.